Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, …
!["Ocugen OCU410 Clinical Trial"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-8460226.webp?resize=600%2C400&ssl=1)
!["Ocugen OCU410 Clinical Trial"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-8460226.webp?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, …
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation …
Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to begin …